VENTXP7

Across TCGA pan-cancer cohorts, VENTXP7 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated VENTXP7 data layer compared with 12 for mass-spec protein.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher VENTXP7 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated VENTXP7 expression acts as an unfavorable survival marker.

ESCA and LUAD are the cancer types where VENTXP7 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Median	II,III,IV	0.206	0.686	.004	12	view →
LUAD	OS	Median	All	0.237	0.788	.008	9	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

VENTXP7–ESCA (OS)

Open the ESCA breakdown →